ArticleBiology2026

Design and Biological Evaluation of ALKBH2 and ALKBH5 Inhibitors as Adjuvants to Temozolomide-Based Glioblastoma Treatment.

Mirko Rivara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.